RSS

Emicizumab

The European Commission (EC) has approved Roche’s routine prophylactic treatment in people with haemophilia A with factor VIII inhibitors, Hemlibra (emicizumab). more

News

The EU Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Hemlibra (emicizumab) — Roche’s prophylactic treatment for people with haemophilia A with inhibitors. more

News

Biotech company, Roche, has announced that the US FDA has accepted its biologics licence application (BLA) and granted priority review for its once-weekly subcutaneous treatment for haemophilia A with factor VIII inhibitors more

News